Effects of Spermidine on Gut Microbiota Modulation in Experimental Abdominal Aortic Aneurysm Mice

Shuai Liu1, Yu Liu1, Jiani Zhao1

  • 1Department of General & Vascular Surgery, Xiangya Hospital, Central South University, Changsha 410008, China.

Nutrients
|August 26, 2022
PubMed

Insights

Gut microbiota alterations are linked to abdominal aortic aneurysm (AAA) progression. Supplementing with spermidine reversed these changes, suggesting its therapeutic potential for AAA and gut dysbiosis.

Area of Science:

  • Microbiology
  • Cardiovascular Research
  • Gastroenterology

Background:

  • Gut microbiota plays a crucial role in cardiovascular health.
  • The specific functions of gut microbiota in abdominal aortic aneurysm (AAA) remain largely unknown.
  • Investigating the gut microbiome's role in AAA is essential for understanding disease mechanisms.

Purpose of the Study:

  • To explore the impact of gut microbiota on the development of abdominal aortic aneurysm (AAA).
  • To investigate the potential therapeutic effects of spermidine on AAA progression and associated gut dysbiosis.
  • To identify specific bacterial taxa linked to AAA development.

Main Methods:

  • Establishment of a porcine pancreatic elastase-infused experimental AAA mouse model.
  • 16S rDNA sequencing for gut microbiota composition and functional analysis.
  • Administration of exogenous spermidine via drinking water to assess therapeutic effects.

Main Results:

  • Significant alterations in gut microbiota composition and function were observed in the AAA model.
  • Dysregulated spermidine biosynthesis metabolism and transport were identified in the AAA gut microbiome.
  • Exogenous spermidine administration attenuated AAA progression, reduced systemic inflammation, and ameliorated gut dysbiosis.
  • Bacteroides, Parabacteroides, and Prevotella were identified as bacterial genera associated with AAA progression.

Conclusions:

  • Gut microbial dysbiosis is a key feature of abdominal aortic aneurysm (AAA).
  • Spermidine demonstrates therapeutic potential in mitigating AAA progression and associated gut dysbiosis.
  • Targeting gut microbiota and spermidine metabolism offers a promising therapeutic strategy for AAA.

Related Concept Videos